+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Dyslipidemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dyslipidemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 345 Pages
  • Global
From
Rhinosinusitis - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Rhinosinusitis - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 251 Pages
  • Global
From
Pigmented Villonodular Synovitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pigmented Villonodular Synovitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 32 Pages
  • Global
From
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 168 Pages
  • Global
From
Transthyretin - Pipeline Review, H2 2020 - Product Thumbnail Image

Transthyretin - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 116 Pages
  • Global
From
Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 - Thematic Intelligence - Product Thumbnail Image

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 - Thematic Intelligence

  • Report
  • November 2023
  • 25 Pages
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research - Product Thumbnail Image

Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research

  • Report
  • June 2022
  • 16 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022

  • Report
  • December 2022
  • 43 Pages
  • Global
From
Drug Development Sector Scorecard - Q4 2021 Update - Thematic Research - Product Thumbnail Image

Drug Development Sector Scorecard - Q4 2021 Update - Thematic Research

  • Report
  • December 2021
  • 16 Pages
  • Global
From
Advanced Genomics - Key Disruptive Forces to Transform Health and Wellness - Product Thumbnail Image

Advanced Genomics - Key Disruptive Forces to Transform Health and Wellness

  • Report
  • September 2022
  • 33 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021

  • Report
  • December 2021
  • 38 Pages
  • Global
From
Regeneron Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Regeneron Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2024
  • 74 Pages
From
Comprehensive Report on Regeneron Pharmaceuticals, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Regeneron Pharmaceuticals, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report - Product Thumbnail Image

Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

  • SWOT Analysis
  • December 2022
  • 64 Pages
From
Loading Indicator